IMPAACT 2015 - Evaluation of the HIV-1 Reservoir in the Central Nervous System of Perinatally-Infected Youth and Young Adults With Cognitive Impairment
Public ClinicalTrials.gov record NCT03416790. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
IMPAACT 2015 is a cross-sectional, exploratory study that will investigate the central nervous system (CNS) reservoir in perinatally HIV-infected adolescents and young adults on effective antiretroviral therapy with neurocognitive impairment. The study will assess the frequency with which HIV is detected in the cerebral spinal fluid (CSF) in this population and assess whether detectable HIV in the CSF correlates with markers of inflammation and neuronal injury. Findings from this study will advance understanding of the role of the CNS in HIV-1 persistence and its implications for future HIV-1 remission research.
Study identification
- NCT ID
- NCT03416790
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 24 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 13 Years to 24 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 5, 2019
- Primary completion
- Mar 25, 2020
- Completion
- Mar 25, 2020
- Last update posted
- Jul 7, 2020
2019 – 2020
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Southern California (CRS 5048) | Los Angeles | California | 90089 | — |
| David Geffen School of Medicine at University of California, Los Angeles (CRS 5112) | Los Angeles | California | 90095 | — |
| University of California, San Diego Mother-Child-Adolescent HIV Program (CRS 4601) | San Diego | California | 92103 | — |
| University of Colorado, Denver (CRS 5052) | Aurora | Colorado | 80045 | — |
| Emory University School of Medicine (CRS 5030) | Atlanta | Georgia | 30322 | — |
| Johns Hopkins University (CRS 5092) | Baltimore | Maryland | 21287 | — |
| Boston Medical Center Pediatric HIV Program (CRS 5011) | Boston | Massachusetts | 02118 | — |
| Bronx-Lebanon Hospital Center (CRS 5114) | The Bronx | New York | 10457 | — |
| Jacobi Medical Center (CRS 5013) | The Bronx | New York | 10461 | — |
| St. Jude Children's Research Hospital (CRS 6501) | Memphis | Tennessee | 38105 | — |
| Seattle Children's Hospital (CRS 5017) | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03416790, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 7, 2020 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03416790 live on ClinicalTrials.gov.